Alternatives to Sherman Diagnostics

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.